{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:36:16Z","timestamp":1792636576010,"version":"4.5.0"},"reference-count":41,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020T130027ZX"],"award-info":[{"award-number":["2020T130027ZX"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Key Research and Development Project","award":["2020B1111330001"],"award-info":[{"award-number":["2020B1111330001"]}]},{"name":"COVID-19 Emerging Prevention Products, Research Special Fund of Zhuhai City","award":["ZH22036302200024PWC"],"award-info":[{"award-number":["ZH22036302200024PWC"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671472"],"award-info":[{"award-number":["31671472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800072"],"award-info":[{"award-number":["81800072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2021,9,14]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with few treatment options. The poor success in developing anti-IPF strategies has impelled researchers to reconsider the importance of the choice of animal model and assessment methodologies. Currently, it is still not settled whether the bleomycin-induced lung fibrosis mouse model finally returns to resolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study aimed to follow the dynamic fibrotic features of bleomycin-treated mouse lungs over extended durations through a combination of the latest technologies (micro-computed tomography imaging and histological detection of degraded collagens) and traditional methods. In addition, we also applied immunohistochemistry to explore the distribution of all hydroxyproline-containing molecules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>As determined by classical biochemical methods, total lung hydroxyproline contents reached a peak at 4\u2005weeks after bleomycin injury and maintained a steady high level thereafter until the end of the experiments (16\u2005weeks). This result seemed to partially contradict with the changes of other fibrosis evaluation parameters, which indicated a gradual degradation of collagens and a recovery of lung aeration after the fibrosis peak. This inconsistency was well reconciled by our data from immunostaining against hydroxyproline and fluorescent peptide staining against degraded collagen, together showing large amounts of hydroxyproline-rich degraded collagen fragments detained and enriched within the intracellular regions at 10 or 16\u2005weeks rather than at 4\u2005weeks after bleomycin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our present data not only offer respiratory researchers a new perspective towards the resolution nature of mouse lung fibrosis, but also remind them to be cautious when using the hydroxyproline content assay to evaluate the severity of fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.00864-2021","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T10:47:07Z","timestamp":1632480427000},"page":"2100864","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":113,"title":["Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis"],"prefix":"10.1183","volume":"59","author":[{"given":"Shengren","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gencheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanshan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"2024102102404323000_59.5.2100864.1","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2024102102404323000_59.5.2100864.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02384-2016"},{"key":"2024102102404323000_59.5.2100864.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01105-2019"},{"key":"2024102102404323000_59.5.2100864.4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.drudis.2020.09.019","article-title":"Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities","volume":"25","author":"Cruwys","year":"2020","journal-title":"Drug Discov Today"},{"key":"2024102102404323000_59.5.2100864.5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S2213-2600(17)30122-4","article-title":"Clinical trial research in focus: why do so many clinical trials fail in IPF?","volume":"5","author":"Spagnolo","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102102404323000_59.5.2100864.6","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0096ST"},{"key":"2024102102404323000_59.5.2100864.7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring animal models that resemble idiopathic pulmonary fibrosis","volume":"4","author":"Tashiro","year":"2017","journal-title":"Front Med"},{"key":"2024102102404323000_59.5.2100864.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02133-2017"},{"key":"2024102102404323000_59.5.2100864.9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","article-title":"The bleomycin model of pulmonary fibrosis","volume":"1627","author":"Liu","year":"2017","journal-title":"Methods Mol Biol"},{"key":"2024102102404323000_59.5.2100864.10","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00313.2007"},{"key":"2024102102404323000_59.5.2100864.11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.2006132"},{"key":"2024102102404323000_59.5.2100864.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61214-X"},{"key":"2024102102404323000_59.5.2100864.13","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2003-0029OC"},{"key":"2024102102404323000_59.5.2100864.14","doi-asserted-by":"publisher","DOI":"10.1002\/phy2.249"},{"key":"2024102102404323000_59.5.2100864.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00182412"},{"key":"2024102102404323000_59.5.2100864.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007313"},{"key":"2024102102404323000_59.5.2100864.17","doi-asserted-by":"crossref","first-page":"e0193057","DOI":"10.1371\/journal.pone.0193057","article-title":"A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat model","volume":"13","author":"Seger","year":"2018","journal-title":"PLoS One"},{"key":"2024102102404323000_59.5.2100864.18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/jcm8030399","article-title":"High-resolution computed tomography (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF): relationship with lung pathology","volume":"8","author":"Cocconcelli","year":"2019","journal-title":"J Clin Med"},{"key":"2024102102404323000_59.5.2100864.19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40248-017-0089-0","article-title":"Longitudinal assessment of bleomycin-induced lung fibrosis by micro-CT correlates with histological evaluation in mice","volume":"12","author":"Ruscitti","year":"2017","journal-title":"Multidiscip Respir Med"},{"key":"2024102102404323000_59.5.2100864.20","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0b013e31816900ec"},{"key":"2024102102404323000_59.5.2100864.21","first-page":"56443","article-title":"A multimodal imaging approach based on micro-CT and fluorescence molecular tomography for longitudinal assessment of bleomycin-induced lung fibrosis in mice","volume":"134","author":"Ruscitti","year":"2018","journal-title":"J Vis Exp"},{"key":"2024102102404323000_59.5.2100864.22","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0032TR"},{"key":"2024102102404323000_59.5.2100864.23","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.1038\/s41598-020-71293-3","article-title":"In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach","volume":"10","author":"Mecozzi","year":"2020","journal-title":"Sci Rep"},{"key":"2024102102404323000_59.5.2100864.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190678"},{"key":"2024102102404323000_59.5.2100864.25","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(90)90076-L"},{"key":"2024102102404323000_59.5.2100864.26","first-page":"349","article-title":"A novel method for accurate collagen and biochemical assessment of pulmonary tissue utilizing one animal","volume":"4","author":"Kliment","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"2024102102404323000_59.5.2100864.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62470-4"},{"key":"2024102102404323000_59.5.2100864.28","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213064"},{"key":"2024102102404323000_59.5.2100864.29","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b03150"},{"key":"2024102102404323000_59.5.2100864.30","doi-asserted-by":"publisher","DOI":"10.3109\/01902149509031745"},{"key":"2024102102404323000_59.5.2100864.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2011.06.019"},{"key":"2024102102404323000_59.5.2100864.32","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00418.2012"},{"key":"2024102102404323000_59.5.2100864.33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40053"},{"key":"2024102102404323000_59.5.2100864.34","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X"},{"key":"2024102102404323000_59.5.2100864.35","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0485OC"},{"key":"2024102102404323000_59.5.2100864.36","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20050675"},{"key":"2024102102404323000_59.5.2100864.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.03.054"},{"key":"2024102102404323000_59.5.2100864.38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008182"},{"key":"2024102102404323000_59.5.2100864.39","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00320.2012"},{"key":"2024102102404323000_59.5.2100864.40","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fphar.2020.01117","article-title":"Quantification of lung fibrosis in IPF-like mouse model and pharmacological response to treatment by micro-computed tomography","volume":"11","author":"Ruscitti","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024102102404323000_59.5.2100864.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.01.018"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00864-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:47:47Z","timestamp":1740358067000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00864-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,5]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1183\/13993003.00864-2021"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00864-2021","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}